Clinical Trial Update: N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation. [Phase 3]

View source ↗

Summary

Phase 3 trial investigating N-acetylcysteine to prevent oral mucositis after autologous hematopoietic cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucositis
• Transplant-related Disorder

Drugs mentioned

• N-Acetyl-Cysteine (N-acetylcysteine)

Snippet

Sponsor: moshe yeshurun | Conditions: Mucositis, Transplant-Related Disorder | Phase 3 | Status: UNKNOWN